Fang EF, Scheibye-Knudsen M, Jahn HJ, Li J, Ling L, Guo H, et al. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24(Pt B):197–205.
Article
Google Scholar
Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 2005;11(6):437–41.
Article
Google Scholar
Hajat C, Stein E. The global burden of multiple chronic conditions: a narrative review. Prev Med Rep. 2018;12:284–93.
Article
Google Scholar
Wang LM, Chen ZH, Zhang M, Zhao ZP, Huang ZJ, Zhang X, et al. Study of the prevalence and disease burden of chronic disease in the elderly in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(3):277–83.
CAS
Google Scholar
Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443–52.
Article
Google Scholar
Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.
Article
Google Scholar
Rodrigues MC, Oliveira C. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 2016;24: e2800.
Article
Google Scholar
Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31(4):283–9.
Article
CAS
Google Scholar
Abdulah R, Insani WN, Destiani DP, Rohmaniasari N, Mohenathas ND, Barliana MI. Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Ther Clin Risk Manag. 2018;14:1591–7.
Article
Google Scholar
Troncoso-Mariño AA-O, López-Jiménez T, Roso-Llorach A, Villén N, Amado-Guirado E, Guisado-Clavero M, et al. Medication-related problems in older people in Catalonia: a real-world data study. Pharmacoepidemiol Drug Saf. 2021;30(2):220–8.
Article
Google Scholar
Alwhaibi M. Potentially inappropriate medications use among older adults with comorbid diabetes and hypertension in an ambulatory care setting. J Diabetes Res. 2022;2022:1591511.
Article
Google Scholar
Fernández A, Gómez F, Curcio CL, Pineda E, Fernandes de Souza J. Prevalence and impact of potentially inappropriate medication on community-dwelling older adults. Biomedica. 2021;41(1):111–22.
Article
Google Scholar
Troncoso-Mariño A, Roso-Llorach AA-O, López-Jiménez T, Villen N, Amado-Guirado E, Fernández-Bertolin S, et al. Medication-related problems in older people with multimorbidity in Catalonia: a real-world data study with 5 years’ follow-up. J Clin Med. 2021;10(4):709.
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
The 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–694.
Tesfaye BT, Tessema MT, Yizengaw MA, Bosho DD. Potentially inappropriate medication use among older adult patients on follow-up at the chronic care clinic of a specialized teaching hospital in Ethiopia. a cross-sectional study. BMC Geriatr. 2021;21(1):530.
Article
Google Scholar
Almodóvar AS, Nahata MC. Associations between chronic disease, polypharmacy, and medication-related problems among medicare beneficiaries. J Manag Care Spec Pharm. 2019;25(5):573–7.
Google Scholar
Chen Q, Zhang L. Analysis of potentially inappropriate medications (PIM) used in elderly outpatients in departments of internal medicine by using the Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) criteria. Ann Palliat Med. 2021;10(4):4678–86.
Fu M, Wushouer H, Nie X, Shi L, Guan X, Ross-Degnan D. Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China. Pharmacoepidemiol Drug Saf. 2020;29(8):923–30.
Article
Google Scholar
Meng L, Qu C, Qin X, Huang H, Hu Y, Qiu F, et al. Drug-related problems among hospitalized surgical elderly patients in China. Biomed Res Int. 2021;2021:8830606.
Article
Google Scholar
Yang J, Meng L, Liu Y, Lv L, Sun S, Long R, et al. Drug-related problems among community-dwelling older adults in mainland China. Int J Clin Pharm. 2018;40(2):368–75.
Article
Google Scholar
Schöttker B, Saum KU, Muhlack DC, Hoppe LK, Holleczek B, Brenner H. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication. Eur J Clin Pharmacol. 2017;73(8):1041–8.
Article
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Article
CAS
Google Scholar
Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the pharmaceutical care project in Minnesota. Am Pharm. 1995;Ns35(4):30–9.
Article
CAS
Google Scholar
Baré M, Lleal M, Ortonobes S, Gorgas MQ, Sevilla-Sánchez D, Carballo N, et al. Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study. BMC Geriatr. 2022;22(1):44.
Article
Google Scholar
Perpétuo C, Plácido AI, Rodrigues D, Aperta J, Piñeiro-Lamas M, Figueiras A, et al. Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: concordance and overlap among the EU(7)-PIM list and Beers and STOPP criteria. Front Pharmacol. 2021;12: 676020.
Article
Google Scholar
Tian F, Liao S, Chen Z, Xu T. The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study. Ann Transl Med. 2021;9(18):1483.
Article
CAS
Google Scholar
Ma Z, Zhang C, Cui X, Liu L. Comparison of three criteria for potentially inappropriate medications in Chinese older adults. Clin Interv Aging. 2019;14:65–72.
Article
Google Scholar
Zeng Y, Yu Y, Liu Q, Su S, Lin Y, Gu H, et al. Comparison of the prevalence and nature of potentially inappropriate medication use in geriatric outpatients between tertiary and community healthcare settings: a multicenter cross-sectional study. Int J Clin Pharm. 2022;44(3):619–29.
Article
Google Scholar
Writing Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1–167.
Dixit D, Kimborowicz K. Pharmacologic management of chronic stable angina. JAAPA. 2015;28(6):1–8.
Sheikh-Taha M, Dimassi H. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovasc Disord. 2017;17(1):189.
Article
Google Scholar
Wang P, Wang Q, Li F, Bian M, Yang K. Relationship between potentially inappropriate medications and the risk of hospital readmission and death in hospitalized older patients. Clin Interv Aging. 2019;14:1871–8.
Article
Google Scholar
Clarke K, Adler N, Agrawal D, Bhakta D, Sata SS, Singh S, et al. Reducing overuse of proton pump inhibitors for stress ulcer prophylaxis and nonvariceal gastrointestinal bleeding in the hospital: a narrative review and implementation guide. J Hosp Med. 2021;16(7):417–23.
Article
Google Scholar
Mafi JN, May FP, Kahn KL, Chong M, Corona E, Yang L, et al. Low-value proton pump inhibitor prescriptions among older adults at a large academic health system. J Am Geriatr Soc. 2019;67(12):2600–4.
Article
Google Scholar
Alsinnari YM, Alqarni MS, Attar M, Bukhari ZM, Almutairi M, Baabbad FM, et al. Risk factors for recurrence of peptic ulcer disease: a retrospective study in tertiary care referral center. Cureus. 2022;14(2): e22001.
Google Scholar
Paisansirikul A, Ketprayoon A, Ittiwattanakul W, Petchlorlian A. Prevalence and associated factors of drug-related problems among older people: a cross-sectional study at King Chulalongkorn memorial hospital in Bangkok. Drugs Real World Outcomes. 2021;8(1):73–84.
Article
Google Scholar
Kefale B, Degu A, Tegegne GT. Medication-related problems and adverse drug reactions in Ethiopia: a systematic review. Pharmacol Res Perspect. 2020;8(5): e00641.
Article
Google Scholar
Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–8.
Google Scholar
Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39(2):109–16.
Article
Google Scholar
Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs aging. 2012;29(6):463–75.
Article
CAS
Google Scholar
Moudallel S, Steurbaut S, Cornu P, Dupont A. Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing. Front Pharmacol. 2018;9:1220.
Article
CAS
Google Scholar
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1-12.
Article
Google Scholar
Nobili A, Marengoni A, Tettamanti M, Salerno F, Pasina L, Franchi C, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med. 2011;22(6):597–602.
Article
Google Scholar
Arauna D, Cerda A, García-García JF, Wehinger S, Castro F, Méndez D, et al. Polypharmacy is associated with frailty, nutritional risk and chronic disease in chilean older adults: remarks from PIEI-ES study. Clin Interv Aging. 2020;15:1013–22.
Article
Google Scholar
Ma Z, Sun S, Zhang C, Yuan X, Chen Q, Wu J, et al. Characteristics of drug-related problems and pharmacists’ interventions in a geriatric unit in China. Int J Clin Pharm. 2021;43(1):270–4.
Wuyts J, Maesschalck J, De Wulf I, Lelubre M, Foubert K, De Vriese C, et al. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): drug-related problems and associated variables. Res Social Adm Pharm. 2020;16(8):1100–10.
Article
Google Scholar